MBRX 8-K 2026-01-12

Moleculin Biotech, Inc. (MBRX) 8-K dated 2026-01-12 — accession 0001437749-26-001050. This URL is the filing, not the MBRX hub.

Moleculin Biotech, Inc. (MBRX) is a biotechnology company listed on US.

Moleculin Biotech, Inc. filed a 8-K on 2026-01-12. Accession 0001437749-26-001050.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.

Not investment advice. The MBRX SEC hub lists recent forms. The stock page is the research view.